Searched for
USFDA OIA
Jhunjhunwala’s pharma bet dives after 'optically' good Q1; targets cutICICI Securities said Lupin’s performance was below expectations due to a dip in US sales and lower gross margin. It said US sales would re...
- Load More
Jhunjhunwala’s pharma bet dives after 'optically' good Q1; targets cutUS Stock: S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
Tourism sector can create 100 million more jobs by 2047: FAITH
National realty companies expand base in NCR, target affluent clients
Govt draws up contingency plans for 315 districts amid 42% rain deficit
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
ED carries out searches at locations linked to Rajesh Exports
Tata Power's Mundra thermal plant to continue operations till Sept 30 under Centre's directions
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service